Sie sind hier

Startseite » Seoul

DAEWON PHARMACEUTICAL CO., LTD

DAEWON PHARMACEUTICAL CO., LTD ist ein Südkorea Unternehmen, befindet sich in 467-24 Kunja-Dong, Kwangjin-Ku Seoul, 143-838. Mehr Einzelheiten sind wie folgt:

Unternehmensinformation

  • Name des Unternehmens: DAEWON PHARMACEUTICAL CO., LTD
  • Land: South Korea
  • Adresse: 467-24 Kunja-Dong, Kwangjin-Ku Seoul, 143-838
  • Internationale Vorwahl: 82
  • Telefonieren: 82-2-4989100
  • Fax: 82-2-4999110
  • Kontakt: Daewon Pharm
  • Webseite:
  • Artikelliste: Medicine, Health, and Environment Finished Medicines, Drugs, and Pharmaceuticals
  • Arbeitnehmer: 101 - 500
  • Typ: Manufacturer
  • Gründungsjahr: 1959
  • Profil: At the great turning point of the 21st century, our company reviews the past 42 years as striving for a <b>healthy society and is now preparing a powerful take-off f</b>or the coming new century. <p><b>Our half-century experiences</b> have been encountered by many predicaments   and have witnessed a series of hard endeavors leading to a road of better health   for the general public; Daewon prides itself on being manufacturer of specialized   ethical drugs.</p> <p><b>Daewon,</b> aiming for the highest quality in its products, has completed   the GMP system for all its production lines and has invested on the Central   Research Laboratory in order to realize the aim of having a reputation for being   a research-oriented company. Daewon is also advancing into the overseas market   for pharmaceutical export and to opening of an affluent society with expanding   to become a reliable pharmaceutical company.</p> <p>With the company's ideology <b>'Growth through the realization of human health'</b>,   Daewon will continue its effort for social responsibility in the future.</p>
  • Bereich: Seoul
Weitere Links

  • DAEWON PARTITION CO., LTD.
  • DAEWON PHARM. CO., LTD.
  • DAEWON PHARMACEUTICAL CO., LTD
  • DAEWON PHARMACEUTICAL CO., LTD.
  • DAEWON PHARMACEUTICAL CO., LTD.

    •         ‹ vorherige Seite | nächste Seite ›
    • Zum Verfassen von Kommentaren bitte Anmelden.